The Relaxin Gene Knockout Mouse: A Model of Progressive Scleroderma
- 1 October 2005
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 125 (4) , 692-699
- https://doi.org/10.1111/j.0022-202x.2005.23880.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Skin aging and sex hormones in women – clinical perspectives for intervention by hormone replacement therapyExperimental Dermatology, 2004
- Relaxin-1–deficient mice develop an age-related progression of renal fibrosisKidney International, 2004
- Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro cultureMolecular Human Reproduction, 2004
- Scleroderma: a treatable disease.Cleveland Clinic Journal of Medicine, 2003
- Relaxin deficiency in mice is associated with an age‐related progression of pulmonary fibrosisThe FASEB Journal, 2002
- Human Relaxin Gene 3 (H3) and the Equivalent Mouse Relaxin (M3) GeneJournal of Biological Chemistry, 2002
- Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivoGut, 2001
- Relaxin decreases renal interstitial fibrosis and slows progression of renal diseaseKidney International, 2001
- Human Relaxin Decreases Collagen Accumulation In Vivo in Two Rodent Models of FibrosisJournal of Investigative Dermatology, 1993
- Relaxin Alone and in Conjunction with Interferon-γ Decreases Collagen Synthesis by Cultured Human Scleroderma FibroblastsJournal of Investigative Dermatology, 1992